Parkinson's disease (PD) is the second most common neurodegenerative disease affecting 1–2% in people >60 and 3–4% in people >80. Genome-wide association (GWA) studies have now implicated significant evidence for association in at least 18 genomic regions. We have studied a large PD-meta analysis and identified a significant excess of SNPs (P < 1 × 10?16) that are associated with PD but fall short of the genome-wide significance threshold. This result was independent of variants at the 18 previously implicated regions and implies the presence of additional polygenic risk alleles. To understand how these loci increase risk of PD, we applied a pathway-based analysis, testing for biological functions that were significantly enriched f...
We performed a genome-wide association study (GWAS) in 1,713 individuals of European ancestry with P...
Parkinson's disease (PD) is a complex disorder underpinned by both environmental and genetic factors...
Background: Genome-wide association studies (GWAS) in Parkinson's disease have increased the scope o...
Parkinson's disease (PD) is the second most common neurodegenerative disease affecting 1-2% in peopl...
Parkinson's disease (PD) is the second most common neurodegenerative disease affecting 1–2% in peopl...
Although the causes of Parkinson's disease (PD) are thought to be primarily environmental, recent st...
Genome-wide association studies (GWAS) have linked dozens of single nucleotide polymorphisms (SNPs) ...
IMPORTANCE: Recent genome-wide association studies (GWAS) and pathway analyses supported long-standi...
Importance:Recent genome-wide association studies (GWAS) and pathway analyses supported long-standin...
IMPORTANCE: Recent genome-wide association studies (GWAS) and pathway analyses supported long-standi...
We conducted a meta-analysis of Parkinson's disease genome-wide association studies using a common s...
We conducted a meta-analysis of Parkinson's disease genome-wide association studies using a common s...
We performed a genome-wide association study (GWAS) in 1,713 individuals of European ancestry with P...
We performed a genome-wide association study (GWAS) in 1,713 individuals of European ancestry with P...
Parkinson's disease (PD) is a complex disorder underpinned by both environmental and genetic factors...
Background: Genome-wide association studies (GWAS) in Parkinson's disease have increased the scope o...
Parkinson's disease (PD) is the second most common neurodegenerative disease affecting 1-2% in peopl...
Parkinson's disease (PD) is the second most common neurodegenerative disease affecting 1–2% in peopl...
Although the causes of Parkinson's disease (PD) are thought to be primarily environmental, recent st...
Genome-wide association studies (GWAS) have linked dozens of single nucleotide polymorphisms (SNPs) ...
IMPORTANCE: Recent genome-wide association studies (GWAS) and pathway analyses supported long-standi...
Importance:Recent genome-wide association studies (GWAS) and pathway analyses supported long-standin...
IMPORTANCE: Recent genome-wide association studies (GWAS) and pathway analyses supported long-standi...
We conducted a meta-analysis of Parkinson's disease genome-wide association studies using a common s...
We conducted a meta-analysis of Parkinson's disease genome-wide association studies using a common s...
We performed a genome-wide association study (GWAS) in 1,713 individuals of European ancestry with P...
We performed a genome-wide association study (GWAS) in 1,713 individuals of European ancestry with P...
Parkinson's disease (PD) is a complex disorder underpinned by both environmental and genetic factors...
Background: Genome-wide association studies (GWAS) in Parkinson's disease have increased the scope o...